speb/financial-data huggingface dataset:
Financial ratios for CNTX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -29923900
Net income: -26725104
Capital expenditures: 7316
Operating cash flow: -14556434
Depreciation & amortization: 10881
Net tangible assets: 95266262
Owner earnings: -26721539
Return on net tangible assets (%): -28.04932033546147
Buffett classification: The Gruesome
Stock price: 1.05
Shares outstanding: 91879177
Book value: 95266262
P/B ratio: 1.0126684287245362
Market cap (USD): 96473135.85000001
Debt to equity: 0.0023028089419526087
Current ratio: 35.618835896672756
Quick ratio: 35.618835896672756
Free cash flow (dilution-adjusted): -30155617
Buyback yield (%): 0
Retained earnings: -94779694
Capitalized R&D asset: 36955848.56
ROCI (R&D-adjusted, %): -17.441431696240947
Rule of 40 score: 0
Financial ratios for CNTX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.05
Shares outstanding: 91879177
Market cap (USD): 96473135.85000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -5529143
Net income: -4577261
Capital expenditures: 33948
Operating cash flow: -5028381
Depreciation & amortization: 4055
Net tangible assets: 90982718
Owner earnings: -4607154
Return on net tangible assets (%): -5.063768264210353
Buffett classification: The Gruesome
Stock price: 0.61
Shares outstanding: 91879177
Book value: 90982718
P/B ratio: 0.6160103721016555
Market cap (USD): 56046297.97
Debt to equity: 0.002129041693390606
Current ratio: 48.801665862347164
Quick ratio: 48.801665862347164
Free cash flow (dilution-adjusted): -5356046
Buyback yield (%): 0
Retained earnings: -99356955
Capitalized R&D asset: 3462991
ROCI (R&D-adjusted, %): -3.406896933681082
Rule of 40 score: 0
Financial ratios for CNTX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -9758362
Net income: -8827510
Capital expenditures: 0
Operating cash flow: -5835180
Depreciation & amortization: 4065
Net tangible assets: 82544322
Owner earnings: -8823445
Return on net tangible assets (%): -10.689342145181106
Buffett classification: The Gruesome
Stock price: 0.65
Shares outstanding: 91879177
Book value: 82544322
P/B ratio: 0.7235078513334934
Market cap (USD): 59721465.050000004
Debt to equity: 0.0020270201020004745
Current ratio: 19.08666112750785
Quick ratio: 19.08666112750785
Free cash flow (dilution-adjusted): -6224294
Buyback yield (%): 0
Retained earnings: -108184465
Capitalized R&D asset: 10150747.97
ROCI (R&D-adjusted, %): -6.137454444016463
Rule of 40 score: 0
Financial ratios for CNTX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -10610480
Net income: -9693237
Capital expenditures: 0
Operating cash flow: -6578864
Depreciation & amortization: 4066
Net tangible assets: 73174166
Owner earnings: -9689171
Return on net tangible assets (%): -13.241245551059647
Buffett classification: The Gruesome
Stock price: 0.97
Shares outstanding: 91879177
Book value: 73174166
P/B ratio: 1.2179544579981958
Market cap (USD): 89122801.69
Debt to equity: 0.001915976739659732
Current ratio: 13.098372636218652
Quick ratio: 13.098372636218652
Free cash flow (dilution-adjusted): -6901945
Buyback yield (%): 0
Retained earnings: -117877702
Capitalized R&D asset: 15111355.51
ROCI (R&D-adjusted, %): -9.693773680571477
Rule of 40 score: 0
Financial ratios for CNTX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -39702631
Net income: -36123615
Capital expenditures: 33948
Operating cash flow: -26385380
Depreciation & amortization: 16251
Net tangible assets: 60473727
Owner earnings: -36141312
Return on net tangible assets (%): -59.763659018403146
Buffett classification: The Gruesome
Stock price: 1.47
Shares outstanding: 91879177
Book value: 60473727
P/B ratio: 2.23340609038368
Market cap (USD): 135062390.19
Debt to equity: 0.001853102257117376
Current ratio: 8.522861915543823
Quick ratio: 8.522861915543823
Free cash flow (dilution-adjusted): -29750408
Buyback yield (%): 0
Retained earnings: -130903309
Capitalized R&D asset: 52934447.68000001
ROCI (R&D-adjusted, %): -28.18122981303003
Rule of 40 score: 0
Financial ratios for CNTX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -13804646
Net income: -13025607
Capital expenditures: 0
Operating cash flow: -8942955
Depreciation & amortization: 4065
Net tangible assets: 60473727
Owner earnings: -13021542
Return on net tangible assets (%): -21.532560743279475
Buffett classification: The Gruesome
Stock price: 1.47
Shares outstanding: 91879177
Book value: 60473727
P/B ratio: 2.23340609038368
Market cap (USD): 135062390.19
Debt to equity: 0.001853102257117376
Current ratio: 8.522861915543823
Quick ratio: 8.522861915543823
Free cash flow (dilution-adjusted): -11268123
Buyback yield (%): 0
Retained earnings: -130903309
Capitalized R&D asset: 20268502.2
ROCI (R&D-adjusted, %): -14.154245487853503
Rule of 40 score: 0
Financial ratios for CPHI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 240
Shares outstanding: 40522002
Market cap (USD): 9725280480
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPHI — annual report dated 2022-12-31
Total revenue: 1164381.0344827587
Gross profit: -70964.94252873563
Operating income: -523394.8275862069
Net income: -570810.4885057472
Capital expenditures: 57753.44827586207
Operating cash flow: -58842.6724137931
Depreciation & amortization: 388007.6149425287
Net tangible assets: 298575.4310344828
Owner earnings: -240556.32183908054
Return on net tangible assets (%): -80.56802296344955
Buffett classification: The Gruesome
Stock price: 50
Shares outstanding: 40522002
Book value: 616379.0229885059
P/B ratio: 3287.1009953850785
Market cap (USD): 2026100100
Debt to equity: 2.0413063129633153
Current ratio: 0.46819504802680995
Quick ratio: 0.2368045488944693
Interest coverage ratio: -8.381658418062717
COGS to revenue (%): 106.09464946844139
R&D to revenue (%): 2.2933846259395865
SG&A to revenue (%): 36.56244277582238
Free cash flow (dilution-adjusted): -127841.8103448276
Buyback yield (%): 0
Retained earnings: -5202801.149425288
Inventory turnover: 2.9167670527076757
Receivables turnover: 17.448642922657573
Capitalized R&D asset: 26703.735632183907
ROCI (R&D-adjusted, %): -67.27628979008085
FCF margin (%): -10.979379306157925
Rule of 40 score: -10.979379306157925
Financial ratios for CPHI — annual report dated 2023-12-31
Total revenue: 986118.0028129395
Gross profit: -39533.7552742616
Operating income: -389251.33614627284
Net income: -433026.4416315049
Capital expenditures: 1619.831223628692
Operating cash flow: -98408.72011251758
Depreciation & amortization: 387292.9676511955
Net tangible assets: 534698.3122362869
Owner earnings: -47353.30520393814
Return on net tangible assets (%): -8.856079048742608
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 40522002
Book value: 1048469.9015471167
P/B ratio: 231.8922189766589
Market cap (USD): 243132012
Debt to equity: 0.6216301271385896
Current ratio: 0.8792300866895071
Quick ratio: 0.3319934833324146
Interest coverage ratio: -8.29609412470024
COGS to revenue (%): 104.00902885471008
R&D to revenue (%): 3.424187158470919
SG&A to revenue (%): 32.03988305162852
Free cash flow (dilution-adjusted): -100028.55133614627
Buyback yield (%): 0
Retained earnings: -5526063.853727144
Inventory turnover: 1.9537443499922438
Receivables turnover: 9.62684554727608
Capitalized R&D asset: 51658.028893253795
ROCI (R&D-adjusted, %): -26.665917492204194
Rosenberg metric: 1.1770333442259102
FCF margin (%): -10.143669525433161
Revenue growth (%): -15.30968183014139
Rule of 40 score: -25.45335135557455
Financial ratios for CPHI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.4
Shares outstanding: 40522002
Market cap (USD): 97252804.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPHI — quarterly report dated 2024-12-31
Capital expenditures: 37376.98630136986
Buffett classification: The Gruesome
Stock price: 2.3
Shares outstanding: 40522002
Market cap (USD): 93200604.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPHI — annual report dated 2024-12-31
Total revenue: 620401.2328767123
Gross profit: -272006.5753424658
Operating income: -627830.6849315069
Net income: -648817.1232876712
Capital expenditures: 5261.780821917809
Operating cash flow: -55625.068493150684
Depreciation & amortization: 366711.9178082192
Net tangible assets: 90497.53424657535
Owner earnings: -287366.98630136985
Return on net tangible assets (%): -317.54123324331846
Buffett classification: The Gruesome
Stock price: 2.3
Shares outstanding: 40522002
Book value: 1061356.712328767
P/B ratio: 87.81270567885198
Market cap (USD): 93200604.6
Debt to equity: 0.4834051893260423
Current ratio: 0.6518240531538153
Quick ratio: 0.2001549442647103
Interest coverage ratio: -29.733774490722723
COGS to revenue (%): 143.84365486851308
R&D to revenue (%): 6.269517583516985
SG&A to revenue (%): 51.084351289234164
Free cash flow (dilution-adjusted): -95586.43835616439
Buyback yield (%): 0
Retained earnings: -6031051.91780822
Inventory turnover: 2.8747282841324995
Receivables turnover: 16.113285752913885
Capitalized R&D asset: 70331.96957537503
ROCI (R&D-adjusted, %): -43.73230545631113
Rosenberg metric: -6.884712390390419
FCF margin (%): -15.407196712511945
Revenue growth (%): -37.08651184675729
Rule of 40 score: -52.49370855926924
Financial ratios for CPHI — quarterly report dated 2025-03-31
Total revenue: 156513.3608815427
Gross profit: -18741.184573002756
Operating income: -104492.83746556473
Net income: -108205.50964187329
Capital expenditures: 8033.608815426997
Operating cash flow: -10148.209366391186
Depreciation & amortization: 45359.9173553719
Net tangible assets: 1037.741046831956
Owner earnings: -70879.20110192838
Return on net tangible assets (%): -6830.143350146004
Buffett classification: The Gruesome
Stock price: 2.6
Shares outstanding: 40522002
Book value: 960034.1597796143
P/B ratio: 109.74318374690526
Market cap (USD): 105357205.2
Debt to equity: 0.5030784028575659
Current ratio: 0.5566076655101245
Quick ratio: 0.1702418859336138
Interest coverage ratio: -27.066433566433567
COGS to revenue (%): 111.97417553839833
R&D to revenue (%): 2.603831602403266
SG&A to revenue (%): 52.30131120042736
Free cash flow (dilution-adjusted): -18181.818181818184
Buyback yield (%): 0
Retained earnings: -6172486.363636364
Inventory turnover: 0.6429513501822715
Receivables turnover: 3.088181178267522
Capitalized R&D asset: 4075.34435261708
ROCI (R&D-adjusted, %): -8.097653756076536
FCF margin (%): -11.616783435874916
Rule of 40 score: -11.616783435874916
Financial ratios for CPHI — quarterly report dated 2025-06-30
Total revenue: 143063.73779637378
Gross profit: -12135.28591352859
Operating income: -69934.44909344491
Net income: -73691.35285913528
Capital expenditures: 9.06555090655509
Operating cash flow: 42808.08926080893
Depreciation & amortization: 44750.76708507671
Net tangible assets: -51824.965132496516
Owner earnings: -28949.651324965125
Buffett classification: The Gruesome
Stock price: 1.79
Shares outstanding: 40522002
Book value: 901219.5258019526
P/B ratio: 80.48470045681167
Market cap (USD): 72534383.58
Debt to equity: 0.5301947895181239
Current ratio: 0.514372206896092
Quick ratio: 0.19464657266569596
Interest coverage ratio: -18.327789758397603
COGS to revenue (%): 108.48243314514893
R&D to revenue (%): 2.042569121447658
SG&A to revenue (%): 52.850793601275925
Free cash flow (dilution-adjusted): 38266.666666666664
Buyback yield (%): 0
Retained earnings: -6323656.624825663
Inventory turnover: 0.6628529595197433
Receivables turnover: 3.234286813346198
Capitalized R&D asset: 5652.656448471017
ROCI (R&D-adjusted, %): -5.810855798487327
Rosenberg metric: 1.620942449987577
FCF margin (%): 26.747984678781826
Revenue growth (%): -8.593274727100313
Rule of 40 score: 18.15470995168151
Financial ratios for CPHI — quarterly report dated 2025-09-30
Total revenue: 106210.25280898876
Gross profit: -8378.370786516854
Operating income: -88164.32584269663
Net income: -91500.2808988764
Capital expenditures: 85.81460674157303
Operating cash flow: -33284.691011235955
Depreciation & amortization: 50004.77528089887
Net tangible assets: -120427.80898876404
Owner earnings: -41581.3202247191
Buffett classification: The Gruesome
Stock price: 1.95
Shares outstanding: 40522002
Book value: 1167696.2078651683
P/B ratio: 67.66991565765541
Market cap (USD): 79017903.89999999
Debt to equity: 0.4291321009617878
Current ratio: 0.35172810437147034
Quick ratio: 0.10263700914687819
Interest coverage ratio: -26.10538135240789
COGS to revenue (%): 107.88847645583213
R&D to revenue (%): 5.331935145599742
SG&A to revenue (%): 66.4978438728566
Free cash flow (dilution-adjusted): -38986.65730337078
Buyback yield (%): 0
Retained earnings: -6459564.606741573
Inventory turnover: 0.494562588426133
Receivables turnover: 2.419042896900291
Capitalized R&D asset: 8965.78317470222
ROCI (R&D-adjusted, %): -6.678223840945298
Rosenberg metric: 1.2856568089287013
FCF margin (%): -36.707056307911614
Revenue growth (%): -25.76018602270794
Rule of 40 score: -62.467242330619555
Financial ratios for CPHI — quarterly report dated 2025-12-31
Total revenue: 175142.42857142858
Gross profit: 21539.285714285714
Operating income: -171537.42857142858
Net income: -174590.7142857143
Capital expenditures: 64.85714285714286
Operating cash flow: 21712.85714285714
Depreciation & amortization: 81851.28571428571
Net tangible assets: -248606.7142857143
Owner earnings: -92804.28571428572
Buffett classification: The Gruesome
Stock price: 1.21
Shares outstanding: 40522002
Book value: 3248536
P/B ratio: 15.093452071948718
Market cap (USD): 49031622.42
Debt to equity: 0.17094254150177188
Current ratio: 0.3170666450100596
Quick ratio: 0.0979660581331257
Interest coverage ratio: -53.12165988320651
COGS to revenue (%): 87.70184592621352
R&D to revenue (%): 15.500935157263843
SG&A to revenue (%): 96.89730072748955
Free cash flow (dilution-adjusted): 20889
Buyback yield (%): 0
Retained earnings: -6744890.714285715
Inventory turnover: 0.6631347896261495
Receivables turnover: 4.217787685818773
Capitalized R&D asset: 31907.28368184047
ROCI (R&D-adjusted, %): -4.592726382018196
Rosenberg metric: 5.282947205816182
FCF margin (%): 11.926864421364815
Revenue growth (%): 64.90162101996802
Rule of 40 score: 76.82848544133283
Financial ratios for CPHI — annual report dated 2025-12-31
Total revenue: 592038.2857142857
Gross profit: -18850
Operating income: -441220
Net income: -455365.14285714284
Capital expenditures: 8474.857142857143
Operating cash flow: 21180.14285714286
Depreciation & amortization: 225595.57142857142
Net tangible assets: -248606.7142857143
Owner earnings: -238244.42857142855
Buffett classification: The Gruesome
Stock price: 1.21
Shares outstanding: 40522002
Book value: 3248536
P/B ratio: 15.093452071948718
Market cap (USD): 49031622.42
Debt to equity: 0.17094254150177188
Current ratio: 0.3170666450100596
Quick ratio: 0.0979660581331257
Interest coverage ratio: -30.268824054019618
COGS to revenue (%): 103.18391571201477
R&D to revenue (%): 6.778060685264562
SG&A to revenue (%): 68.2206121804864
Free cash flow (dilution-adjusted): 1572.857142857143
Buyback yield (%): 0
Retained earnings: -6744890.714285715
Inventory turnover: 2.6373241282503086
Receivables turnover: 14.257492095929102
Capitalized R&D asset: 77332.09800919847
ROCI (R&D-adjusted, %): -12.720647412696861
Rosenberg metric: 6.508522867346149
FCF margin (%): 0.26566814694416485
Revenue growth (%): -4.571710315743846
Rule of 40 score: -4.306042168799681
Financial ratios for CRIZAC.NS — quarterly report dated 2025-09-30
Gross profit: 8001679.819616686
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.2144306651634724
P/E ratio: 51.6756435786465
Shares outstanding: 174982500
Market cap (USD): 562469113.8669673
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRIZAC.NS — quarterly report dated 2025-12-31
Total revenue: 31038877.13044447
Gross profit: 9044970.480115851
Operating income: 6583580.260666147
Net income: 5628573.019939846
Capital expenditures: 0
Depreciation & amortization: 613634.844602874
Owner earnings: 6242207.864542721
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.058594185139802
P/E ratio: 32.410500581173444
Shares outstanding: 174982500
Market cap (USD): 535200457.0012254
Effective tax rate (%): 24.981441229570507
Interest coverage ratio: 19700.266666666666
COGS to revenue (%): 70.8592213497179
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CURV — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.2
Shares outstanding: 99520381
Market cap (USD): 915587505.1999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CURV — annual report dated 2023-01-31
Total revenue: 1288144000
Gross profit: 459539000
Operating income: 101625000
Net income: 50209000
Capital expenditures: 23369000
Operating cash flow: 53311000
Depreciation & amortization: 79431000
Net tangible assets: -238624000
Owner earnings: 106271000
Return on net tangible assets (%): -44.53491685664476
Capex to operating income (%): 22.99532595325953
Buffett classification: The Great
Stock price: 3.72
P/E ratio: 7.373495136728475
Shares outstanding: 99520381
Book value: -230224000
Market cap (USD): 370215817.32
Debt to equity: -2.3778103064841196
Current ratio: 0.8084518211778084
Quick ratio: 0.1349134206421349
Effective tax rate (%): 29.95591640858235
Interest coverage ratio: 3.393948502154093
COGS to revenue (%): 64.3254946651927
SG&A to revenue (%): 27.785247612068215
Free cash flow (dilution-adjusted): 19962000
Buyback yield (%): 8.562573103838988
Retained earnings: -359206000
Inventory turnover: 4.601954958207214
Receivables turnover: 473.4083057699375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.0960117259182
FCF margin (%): 1.5496714653020158
Rule of 40 score: 1.5496714653020158
Financial ratios for CURV — annual report dated 2024-01-31
Total revenue: 1151945000
Gross profit: 405978000
Operating income: 57148000
Net income: 11619000
Capital expenditures: 26002000
Operating cash flow: 42771000
Depreciation & amortization: 79368000
Net tangible assets: -220117000
Owner earnings: 64985000
Return on net tangible assets (%): -29.522935529741
Capex to operating income (%): 45.49940505354518
Buffett classification: The Good
Stock price: 5.16
P/E ratio: 44.197019189258974
Shares outstanding: 99520381
Book value: -211717000
Market cap (USD): 513525165.96000004
Debt to equity: -2.414931252568287
Current ratio: 0.7717259712115533
Quick ratio: 0.15908180278923084
Effective tax rate (%): 35.57527030773496
Interest coverage ratio: 1.457745580695355
COGS to revenue (%): 64.75717156635082
SG&A to revenue (%): 30.281827691426237
Free cash flow (dilution-adjusted): 8727000
Buyback yield (%): 0
Retained earnings: -347587000
Inventory turnover: 5.245937031905991
Receivables turnover: 417.52265313519393
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.34095735990851
FCF margin (%): 0.7575882529113803
Revenue growth (%): -10.57327441652486
Rule of 40 score: -9.81568616361348
Financial ratios for CURV — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.63
Shares outstanding: 99520381
Market cap (USD): 361258983.03
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CURV — quarterly report dated 2025-01-31
Total revenue: 275562000
Gross profit: 92635000
Operating income: 3450000
Net income: -2988000
Capital expenditures: 1775000
Operating cash flow: 12024000
Depreciation & amortization: 19542000
Net tangible assets: -199489000
Owner earnings: 14779000
Capex to operating income (%): 51.449275362318836
Buffett classification: The Good
Stock price: 7.06
Shares outstanding: 99520381
Book value: -191089000
Market cap (USD): 702613889.86
Debt to equity: -2.4405172458906583
Current ratio: 0.8595153763130292
Quick ratio: 0.29518644634632046
Interest coverage ratio: 0.4141656662665066
COGS to revenue (%): 66.38324587570129
SG&A to revenue (%): 32.36476727560404
Free cash flow (dilution-adjusted): 7146000
Buyback yield (%): 0
Retained earnings: -331269000
Inventory turnover: 1.231889718707279
Receivables turnover: 98.06476868327402
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5312304435242268
FCF margin (%): 2.5932458031223464
Rule of 40 score: 2.5932458031223464
Financial ratios for CURV — annual report dated 2025-01-31
Total revenue: 1103737000
Gross profit: 413471000
Operating income: 57208000
Net income: 16318000
Capital expenditures: 14392000
Operating cash flow: 77390000
Depreciation & amortization: 77813000
Net tangible assets: -199489000
Owner earnings: 79739000
Return on net tangible assets (%): -39.97162750828366
Capex to operating income (%): 25.157320654453923
Buffett classification: The Good
Stock price: 7.06
P/E ratio: 43.05759834906238
Shares outstanding: 99520381
Book value: -191089000
Market cap (USD): 702613889.86
Debt to equity: -2.4405172458906583
Current ratio: 0.8595153763130292
Quick ratio: 0.29518644634632046
Effective tax rate (%): 24.46419478776096
Interest coverage ratio: 1.6054780680829568
COGS to revenue (%): 62.538992531735374
SG&A to revenue (%): 32.27788866369434
Free cash flow (dilution-adjusted): 55364000
Buyback yield (%): 0
Retained earnings: -331269000
Inventory turnover: 4.648475012290142
Receivables turnover: 392.78896797153027
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.390907598009843
FCF margin (%): 5.016050019162174
Revenue growth (%): -4.184922023186871
Rule of 40 score: 0.8311279959753026
Financial ratios for CURV — quarterly report dated 2025-04-30
Total revenue: 265965000
Gross profit: 101402000
Operating income: 16027000
Net income: 5940000
Capital expenditures: 2547000
Operating cash flow: -18015000
Depreciation & amortization: 18719000
Net tangible assets: -192221000
Owner earnings: 22112000
Return on net tangible assets (%): -11.503425744325542
Capex to operating income (%): 15.891932364135522
Buffett classification: The Great
Stock price: 6.35
P/E ratio: 26.597408221801345
Shares outstanding: 99520381
Book value: -183821000
Market cap (USD): 631954419.35
Debt to equity: -2.440335979023071
Current ratio: 0.8723449191407193
Quick ratio: 0.22766887348712114
Effective tax rate (%): 30.70461969202053
Interest coverage ratio: 1.9638524690601642
COGS to revenue (%): 61.87393078036584
SG&A to revenue (%): 32.10008835749065
Free cash flow (dilution-adjusted): -22031000
Buyback yield (%): 0
Retained earnings: -325329000
Inventory turnover: 1.1002406899779367
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.305921502484387
FCF margin (%): -8.283420750850675
Revenue growth (%): -3.4827008078036883
Rule of 40 score: -11.766121558654364
Financial ratios for CURV — quarterly report dated 2025-07-31
Total revenue: 262806000
Gross profit: 93488000
Operating income: 10160000
Net income: 1567000
Capital expenditures: 1124000
Operating cash flow: 15745000
Depreciation & amortization: 18448000
Net tangible assets: -209516000
Owner earnings: 18891000
Return on net tangible assets (%): -9.016495160274156
Capex to operating income (%): 11.062992125984252
Buffett classification: The Great
Stock price: 2.49
P/E ratio: 54.836412633325956
Shares outstanding: 99520381
Book value: -201116000
Market cap (USD): 247805748.69000003
Debt to equity: -2.165680502794407
Current ratio: 0.8286304017248708
Quick ratio: 0.2579023712591645
Effective tax rate (%): 23.70983446932814
Interest coverage ratio: 1.2513856386254465
COGS to revenue (%): 64.4269917733994
SG&A to revenue (%): 31.70703865208557
Free cash flow (dilution-adjusted): 13250000
Buyback yield (%): 0
Retained earnings: -323762000
Inventory turnover: 1.3000959803432257
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.454330717115647
FCF margin (%): 5.041741817157903
Revenue growth (%): -1.187750267892392
Rule of 40 score: 3.853991549265511
Financial ratios for CURV — quarterly report dated 2025-10-31
Total revenue: 235153000
Gross profit: 82176000
Operating income: 205000
Net income: -6426000
Capital expenditures: 1753000
Operating cash flow: -4852000
Depreciation & amortization: 16059000
Net tangible assets: -214915000
Owner earnings: 7880000
Capex to operating income (%): 855.1219512195122
Buffett classification: The Gruesome
Stock price: 1.25
Shares outstanding: 99520381
Book value: -206515000
Market cap (USD): 124400476.25
Debt to equity: -2.088138876110694
Current ratio: 0.8105671985495665
Quick ratio: 0.25712972271629764
Interest coverage ratio: 0.025929673665570453
COGS to revenue (%): 65.0542412812084
SG&A to revenue (%): 34.85858143421517
Free cash flow (dilution-adjusted): -7737000
Buyback yield (%): 0.06832771269233787
Retained earnings: -330188000
Inventory turnover: 1.187552885100569
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.1204621043848206
FCF margin (%): -3.290198296428283
Revenue growth (%): -10.522210299612642
Rule of 40 score: -13.812408596040925
Financial ratios for CURV — quarterly report dated 2026-01-31
Total revenue: 236168000
Gross profit: 70896000
Operating income: -4990000
Net income: -8115000
Capital expenditures: 3428000
Operating cash flow: -5891000
Depreciation & amortization: 16239000
Net tangible assets: -221807000
Owner earnings: 4696000
Buffett classification: The Gruesome
Stock price: 1.15
Shares outstanding: 99520381
Book value: -213407000
Market cap (USD): 114448438.14999999
Debt to equity: -2.053569001954013
Current ratio: 0.7772296716451486
Quick ratio: 0.2289686588628494
Interest coverage ratio: -0.6516061634891617
COGS to revenue (%): 69.9806917109854
SG&A to revenue (%): 32.13221096846313
Free cash flow (dilution-adjusted): -10555000
Buyback yield (%): 0
Retained earnings: -338303000
Inventory turnover: 1.2109346951635003
Receivables turnover: 80.1112618724559
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.2958613492556244
FCF margin (%): -4.469276108532909
Revenue growth (%): 0.4316338724149809
Rule of 40 score: -4.037642236117928
Financial ratios for CURV — annual report dated 2026-01-31
Total revenue: 1000092000
Gross profit: 347962000
Operating income: 21402000
Net income: -7034000
Capital expenditures: 8852000
Operating cash flow: -13013000
Depreciation & amortization: 69465000
Net tangible assets: -221807000
Owner earnings: 53579000
Capex to operating income (%): 41.36062050275675
Buffett classification: The Good
Stock price: 1.15
Shares outstanding: 99520381
Book value: -213407000
Market cap (USD): 114448438.14999999
Debt to equity: -2.053569001954013
Current ratio: 0.7772296716451486
Quick ratio: 0.2289686588628494
Interest coverage ratio: 0.6720889335510615
COGS to revenue (%): 65.20700095591205
SG&A to revenue (%): 32.652995924374956
Free cash flow (dilution-adjusted): -27073000
Buyback yield (%): 17.549387588562738
Retained earnings: -338303000
Inventory turnover: 4.7781042327615895
Receivables turnover: 339.2442333785617
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.13587667269917
FCF margin (%): -2.707050951312479
Revenue growth (%): -9.39037107571822
Rule of 40 score: -12.0974220270307
Financial ratios for CYQ.AX — annual report dated 2021-06-30
Total revenue: 2549100
Gross profit: 407791.7293233083
Operating income: -2701706.015037594
Net income: -2419207.5187969925
Capital expenditures: 7886.466165413533
Depreciation & amortization: 74986.46616541353
Net tangible assets: 773744.3609022556
Owner earnings: -2352107.5187969925
Return on net tangible assets (%): -303.99026314766587
Buffett classification: The Gruesome
Stock price: 0.022556390977443608
Shares outstanding: 460516658
Book value: 777515.7894736843
P/B ratio: 13.359977932416331
Market cap (USD): 10387593.789473685
Debt to equity: 0.7706731289938263
Current ratio: 1.3149136132362091
Quick ratio: 1.2593412343723482
Interest coverage ratio: -13.625576853800505
COGS to revenue (%): 84.0025213085674
R&D to revenue (%): 0.8232892458284702
SG&A to revenue (%): 87.32688494214233
Free cash flow (dilution-adjusted): -2099145.864661654
Buyback yield (%): 1.8282291973029996
Retained earnings: -13740381.954887217
Inventory turnover: 21.31691616766467
Receivables turnover: 26.71044214042607
Capitalized R&D asset: 20986.466165413534
ROCI (R&D-adjusted, %): -336.5945454271531
FCF margin (%): -82.34850985295414
Rule of 40 score: -82.34850985295414
Financial ratios for CYQ.AX — annual report dated 2022-06-30
Total revenue: 3102022.7586206896
Gross profit: 1381684.8275862068
Operating income: -687128.9655172414
Net income: -531608.275862069
Capital expenditures: 4380.689655172414
Depreciation & amortization: 177855.1724137931
Net tangible assets: 594732.4137931034
Owner earnings: -358133.7931034483
Return on net tangible assets (%): -60.21763482157145
Buffett classification: The Gruesome
Stock price: 0.006896551724137932
Shares outstanding: 460516658
Book value: 748806.2068965517
P/B ratio: 4.241387053784001
Market cap (USD): 3175976.951724138
Debt to equity: 0.06325931206361575
Current ratio: 1.6544591643812325
Quick ratio: 1.378321455809044
Interest coverage ratio: -3.5121738854558466
COGS to revenue (%): 55.458585087861465
R&D to revenue (%): 0.9099068394304675
SG&A to revenue (%): 37.36334000528687
Free cash flow (dilution-adjusted): -581317.9310344828
Buyback yield (%): 0
Retained earnings: -13175041.379310345
Inventory turnover: 7.604225094500671
Receivables turnover: 126.50990043314395
Capitalized R&D asset: 42286.44957220638
ROCI (R&D-adjusted, %): -84.95425558778697
Rosenberg metric: 46.40576886964944
FCF margin (%): -18.73996344543149
Revenue growth (%): 21.69090104824015
Rule of 40 score: 2.9509376028086614
Financial ratios for CYQ.AX — annual report dated 2023-06-30
Total revenue: 3467298.013245033
Gross profit: 1846658.2781456953
Operating income: -410350.99337748345
Net income: -282394.70198675495
Capital expenditures: 7194.039735099338
Depreciation & amortization: 163606.6225165563
Net tangible assets: 370433.11258278147
Owner earnings: -125982.119205298
Return on net tangible assets (%): -34.00941085609471
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 460516658
Book value: 509198.0132450331
P/B ratio: 5.989377634483001
Market cap (USD): 3049779.19205298
Debt to equity: 0.06185418181297951
Current ratio: 1.3298418235289877
Quick ratio: 0.9820049931146404
Interest coverage ratio: -27.26164811474328
COGS to revenue (%): 46.740710746769246
R&D to revenue (%): 0.7162857503027339
SG&A to revenue (%): 43.1009316948136
Free cash flow (dilution-adjusted): 177035.76158940396
Buyback yield (%): 0
Retained earnings: -12947063.57615894
Inventory turnover: 4.611247515051018
Receivables turnover: 80.83402809942875
Capitalized R&D asset: 50672.39197571458
ROCI (R&D-adjusted, %): -73.26656483865122
Rosenberg metric: 16.473513898190884
FCF margin (%): 5.105870937921392
Revenue growth (%): 11.775389255582464
Rule of 40 score: 16.881260193503856
Financial ratios for DDC — annual report dated 2023-12-31
Total revenue: 205481904
Gross profit: 51455313
Operating income: -139624862
Net income: -161975688
Capital expenditures: 139148
Operating cash flow: -89350546
Depreciation & amortization: 6107400
Net tangible assets: -10816566
Owner earnings: -156007436
Buffett classification: The Gruesome
Stock price: 116.75
Shares outstanding: 47511029
Book value: 60657245
P/B ratio: 91.44682775734375
Market cap (USD): 5546912635.75
Debt to equity: 2.991677086554129
Current ratio: 1.1388863563060228
Quick ratio: 1.1034033836158461
Interest coverage ratio: -11.464707142028997
COGS to revenue (%): 74.95871315266768
R&D to revenue (%): 0
SG&A to revenue (%): 89.4308420463147
Free cash flow (dilution-adjusted): -173415544
Buyback yield (%): 0
Retained earnings: -1644382306
Inventory turnover: 15.427188329443815
Receivables turnover: 2.4852365340173272
Capitalized R&D asset: 77108.79000000001
ROCI (R&D-adjusted, %): -91.27947552483036
FCF margin (%): -84.39455768328874
Revenue growth (%): 14.419736774010072
Rule of 40 score: -69.97482090927866
Financial ratios for DDC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 9891931
Buffett classification: The Gruesome
Stock price: 4.38
Shares outstanding: 47511029
Book value: 82271114
P/B ratio: 2.529421286552653
Market cap (USD): 208098307.01999998
Debt to equity: 2.339355402432013
Current ratio: 1.0176137131410996
Quick ratio: 1.0048787586165293
Buyback yield (%): 0
Retained earnings: -1814578760
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DDC — annual report dated 2024-12-31
Total revenue: 273333957
Gross profit: 77642692
Operating income: -69511457
Net income: -156991074
Capital expenditures: 304903
Operating cash flow: -112907188
Depreciation & amortization: 4673551
Net tangible assets: 9891931
Owner earnings: -152622426
Return on net tangible assets (%): -1542.8982066292215
Buffett classification: The Gruesome
Stock price: 4.38
Shares outstanding: 47511029
Book value: 82271114
P/B ratio: 2.529421286552653
Market cap (USD): 208098307.01999998
Debt to equity: 2.339355402432013
Current ratio: 1.0176137131410996
Quick ratio: 1.0048787586165293
Interest coverage ratio: -4.152672048956893
COGS to revenue (%): 71.59420188688813
SG&A to revenue (%): 50.92124320287069
Free cash flow (dilution-adjusted): -132431588
Buyback yield (%): 0
Retained earnings: -1814578760
Inventory turnover: 41.461735487321086
Receivables turnover: 1.8440148165083061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -60.65603974066216
FCF margin (%): -48.450470425816874
Revenue growth (%): 33.020938427745925
Rule of 40 score: -15.42953199807095
Financial ratios for DDC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 168128283
Buffett classification: The Gruesome
Stock price: 10.9
Shares outstanding: 47511029
Book value: 248615962
P/B ratio: 2.0830127395440523
Market cap (USD): 517870216.1
Debt to equity: 0.605032443572549
Current ratio: 1.1779248718116873
Quick ratio: 1.169227678000235
Buyback yield (%): 0
Retained earnings: -1786435453
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIE.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 114.18181818181819
Shares outstanding: 52586680
Market cap (USD): 6004442734.545455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIE.BR — annual report dated 2022-12-31
Total revenue: 5015531914.893618
Gross profit: 1032553191.4893618
Operating income: 214361702.1276596
Net income: 354042553.1914894
Capital expenditures: 70851063.82978724
Operating cash flow: 93191489.36170213
Depreciation & amortization: 100000000
Net tangible assets: 1428936170.212766
Owner earnings: 383191489.36170214
Return on net tangible assets (%): 26.816557474687315
Capex to operating income (%): 33.05210918114144
Buffett classification: The Good
Stock price: 113.14893617021278
P/E ratio: 16.80624785096154
Shares outstanding: 52586680
Book value: 3357340425.5319147
P/B ratio: 1.7722739265502712
Market cap (USD): 5950126898.723405
Debt to equity: 0.5071770334928231
Current ratio: 1.7747136190072124
Quick ratio: 0.9320463866496959
Effective tax rate (%): 15.14917695473251
Interest coverage ratio: 5.4459459459459465
COGS to revenue (%): 79.41288762567343
SG&A to revenue (%): 16.563441225130443
Free cash flow (dilution-adjusted): -14361702.127659574
Buyback yield (%): 2.0990076202924755
Retained earnings: 3121170212.765958
Inventory turnover: 3.1417303012503144
Receivables turnover: 8.293051890941074
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.0289524723571875
FCF margin (%): -0.28634454672718784
Rule of 40 score: -0.28634454672718784
Financial ratios for DIE.BR — annual report dated 2023-12-31
Total revenue: 8870666666.666666
Gross profit: 2006777777.7777777
Operating income: 417333333.3333333
Net income: 567000000
Capital expenditures: 101777777.77777778
Operating cash flow: 485444444.4444444
Depreciation & amortization: 209000000
Net tangible assets: 1809555555.5555556
Owner earnings: 674222222.2222222
Return on net tangible assets (%): 37.25899545622007
Capex to operating income (%): 24.38764643237487
Buffett classification: The Great
Stock price: 118.78888888888888
P/E ratio: 11.0171310186165
Shares outstanding: 52586680
Book value: 3858777777.7777777
P/B ratio: 1.6188320881108007
Market cap (USD): 6246713287.555555
Debt to equity: 0.46831178553946273
Current ratio: 1.7954162276080083
Quick ratio: 1.03972602739726
Effective tax rate (%): 16.740088105726873
Interest coverage ratio: 3.836567926455567
COGS to revenue (%): 77.37737361591263
SG&A to revenue (%): 18.262437997895688
Free cash flow (dilution-adjusted): 307666666.6666667
Buyback yield (%): 1.4514299359198872
Retained earnings: 3569777777.7777777
Inventory turnover: 4.306979014153245
Receivables turnover: 11.464101091326823
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.684701359720938
FCF margin (%): 3.468360138283481
Revenue growth (%): 76.86392624330092
Rule of 40 score: 80.33228638158441
Financial ratios for DIE.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -2204479166.666667
Buffett classification: The Gruesome
Stock price: 163.84375
Shares outstanding: 52586680
Book value: -461875000
Market cap (USD): 8615998851.25
Debt to equity: -5.98105548037889
Current ratio: 1.4485676741130094
Quick ratio: 0.7953219448094613
Buyback yield (%): 0
Retained earnings: -592812500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIE.BR — annual report dated 2024-12-31
Total revenue: 8494479166.666667
Gross profit: 2049375000
Operating income: 268958333.3333334
Net income: 392500000
Capital expenditures: 112604166.66666667
Operating cash flow: 908125000
Depreciation & amortization: 216354166.6666667
Net tangible assets: -2204479166.666667
Owner earnings: 496250000.00000006
Return on net tangible assets (%): -22.510986155081984
Capex to operating income (%): 41.86676994577846
Buffett classification: The Good
Stock price: 163.84375
P/E ratio: 21.951589429936305
Shares outstanding: 52586680
Book value: -461875000
Market cap (USD): 8615998851.25
Debt to equity: -5.98105548037889
Current ratio: 1.4485676741130094
Quick ratio: 0.7953219448094613
Effective tax rate (%): 19.897959183673468
Interest coverage ratio: 2.749733759318424
COGS to revenue (%): 75.87403583209684
SG&A to revenue (%): 19.233080309514758
Free cash flow (dilution-adjusted): 719166666.6666667
Buyback yield (%): 0.3639063468783755
Retained earnings: -592812500
Inventory turnover: 4.978516253620856
Receivables turnover: 11.170821917808219
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.403708509480559
FCF margin (%): 8.466283247697648
Revenue growth (%): -4.240803021193436
Rule of 40 score: 4.225480226504212
Financial ratios for DIE.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -2168941176.470588
Buffett classification: The Gruesome
Stock price: 211.91764705882352
Shares outstanding: 52586680
Book value: -167529411.76470566
Market cap (USD): 11144045492.235294
Debt to equity: -17.155898876404517
Current ratio: 1.2080648131099248
Quick ratio: 0.6316055974958572
Buyback yield (%): 0
Retained earnings: -484352941.1764706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DWSN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 31052840
Market cap (USD): 61484623.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DWSN — annual report dated 2022-12-31
Total revenue: 51630000
Gross profit: -6746000
Operating income: -22201000
Net income: -18645000
Capital expenditures: 1429000
Operating cash flow: -3269000
Depreciation & amortization: 11830000
Net tangible assets: 48435000
Owner earnings: -8244000
Return on net tangible assets (%): -17.020749458036544
Buffett classification: The Gruesome
Stock price: 1.67
Shares outstanding: 31052840
Book value: 48804000
P/B ratio: 1.0625818129661504
Market cap (USD): 51858242.8
Debt to equity: 0.10103680026227359
Current ratio: 2.7063109793750773
Quick ratio: 2.7063109793750773
Interest coverage ratio: -716.1612903225806
COGS to revenue (%): 113.06604687197365
SG&A to revenue (%): 29.93414681386791
Free cash flow (dilution-adjusted): -4698000
Buyback yield (%): 0
Retained earnings: -112469000
Receivables turnover: 3.1405109489051095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -42.30454086396463
FCF margin (%): -9.099360836722836
Rule of 40 score: -9.099360836722836
Financial ratios for DWSN — annual report dated 2023-12-31
Total revenue: 96846000
Gross profit: 1697000
Operating income: -13070000
Net income: -12147000
Capital expenditures: 3721000
Operating cash flow: 814000
Depreciation & amortization: 8492000
Net tangible assets: 31057000
Owner earnings: -7376000
Return on net tangible assets (%): -23.749879254274397
Buffett classification: The Gruesome
Stock price: 1.56
Shares outstanding: 31052840
Book value: 31434000
P/B ratio: 1.541083870967742
Market cap (USD): 48442430.4
Debt to equity: 0.19832029013170452
Current ratio: 1.6694620394325987
Quick ratio: 1.6694620394325987
Interest coverage ratio: -126.89320388349515
COGS to revenue (%): 98.24773351506515
SG&A to revenue (%): 15.247919377155483
Free cash flow (dilution-adjusted): -2907000
Buyback yield (%): 0
Retained earnings: -123640000
Receivables turnover: 5.6791180437459685
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -37.2354063986781
FCF margin (%): -3.0016727588129606
Revenue growth (%): 87.57699012202208
Rule of 40 score: 84.57531736320912
Financial ratios for DWSN — quarterly report dated 2024-09-30
Capital expenditures: 69000
Buffett classification: The Gruesome
Stock price: 1.58
Shares outstanding: 31052840
Market cap (USD): 49063487.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DWSN — quarterly report dated 2024-12-31
Capital expenditures: 308000
Buffett classification: The Gruesome
Stock price: 1.34
Shares outstanding: 31052840
Market cap (USD): 41610805.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DWSN — annual report dated 2024-12-31
Total revenue: 74154000
Gross profit: 5397000
Operating income: -4549000
Net income: -4119000
Capital expenditures: 1865000
Operating cash flow: -1866000
Depreciation & amortization: 5736000
Net tangible assets: 16933000
Owner earnings: -248000
Return on net tangible assets (%): -1.4645957597590504
Buffett classification: The Gruesome
Stock price: 1.34
Shares outstanding: 31052840
Book value: 17281000
P/B ratio: 2.4078933857994334
Market cap (USD): 41610805.6
Debt to equity: 0.3343556507146577
Current ratio: 1.4643504531722054
Quick ratio: 1.4643504531722054
Interest coverage ratio: -28.61006289308176
COGS to revenue (%): 92.72190306659115
SG&A to revenue (%): 13.412627774631172
Free cash flow (dilution-adjusted): -3731000
Buyback yield (%): 0
Retained earnings: -137619000
Receivables turnover: 7.157031174597047
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.72397325692455
FCF margin (%): -5.031421096636729
Revenue growth (%): -23.431014187472897
Rule of 40 score: -28.462435284109624
Financial ratios for DWSN — quarterly report dated 2025-03-31
Total revenue: 16078000
Gross profit: 14807000
Operating income: 1034000
Net income: 992000
Capital expenditures: 0
Operating cash flow: 1752000
Depreciation & amortization: 1271000
Net tangible assets: 17940000
Owner earnings: 2263000
Return on net tangible assets (%): 12.614269788182831
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.23
P/E ratio: 9.625754334677419
Shares outstanding: 31052840
Book value: 18287000
P/B ratio: 2.0886418329961174
Market cap (USD): 38194993.2
Debt to equity: 0.36206048012249137
Current ratio: 1.5637225844694724
Quick ratio: 1.5637225844694724
Effective tax rate (%): 0.3015075376884422
Interest coverage ratio: 13.605263157894736
COGS to revenue (%): 7.905212091056102
SG&A to revenue (%): 12.402040054733176
Free cash flow (dilution-adjusted): 1752000
Buyback yield (%): 0
Retained earnings: -136627000
Receivables turnover: 1.4575287825219836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.816471026644307
FCF margin (%): 10.896877721109592
Rule of 40 score: 10.896877721109592
Financial ratios for DWSN — quarterly report dated 2025-06-30
Total revenue: 9851000
Gross profit: 8677000
Operating income: -2371000
Net income: -2349000
Capital expenditures: 0
Operating cash flow: 14875000
Depreciation & amortization: 1174000
Net tangible assets: 16046000
Owner earnings: -1175000
Return on net tangible assets (%): -7.32269724541942
Buffett classification: The Gruesome
Stock price: 1.46
Shares outstanding: 31052840
Book value: 16413000
P/B ratio: 2.762270541643819
Market cap (USD): 45337146.4
Debt to equity: 0.3418631572533967
Current ratio: 1.183951779996233
Quick ratio: 1.183951779996233
Interest coverage ratio: -40.87931034482759
COGS to revenue (%): 11.917571820119784
SG&A to revenue (%): 23.66257232768247
Free cash flow (dilution-adjusted): 14192000
Buyback yield (%): 0
Retained earnings: -138976000
Receivables turnover: 0.8973401348150847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.388317048957626
FCF margin (%): 144.0665922241397
Revenue growth (%): -38.72994153501679
Rule of 40 score: 105.3366506891229
Financial ratios for DWSN — quarterly report dated 2025-09-30
Total revenue: 22746000
Gross profit: 938000
Operating income: -1172000
Net income: -1153000
Capital expenditures: 5434000
Operating cash flow: -4736000
Depreciation & amortization: 1349000
Net tangible assets: 14830000
Owner earnings: -5238000
Return on net tangible assets (%): -35.32029669588672
Buffett classification: The Gruesome
Stock price: 1.76
Shares outstanding: 31052840
Book value: 15189000
P/B ratio: 3.5981959576008955
Market cap (USD): 54652998.4
Debt to equity: 0.8893278030153401
Current ratio: 0.7974599334744481
Quick ratio: 0.7974599334744481
Interest coverage ratio: -16.507042253521128
COGS to revenue (%): 95.87619801283742
SG&A to revenue (%): 9.276356282423283
Free cash flow (dilution-adjusted): -10170000
Buyback yield (%): 0
Retained earnings: -140129000
Receivables turnover: 10.477199447259327
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.875207986688852
FCF margin (%): -44.71115800580322
Revenue growth (%): 130.90041620140087
Rule of 40 score: 86.18925819559766
Financial ratios for DWSN — quarterly report dated 2025-12-31
Total revenue: 26950000
Gross profit: 3420000
Operating income: 845000
Net income: 569000
Capital expenditures: 714000
Operating cash flow: 2086000
Depreciation & amortization: 1876000
Net tangible assets: 15444000
Owner earnings: 1731000
Return on net tangible assets (%): 11.208236208236208
Capex to operating income (%): 84.49704142011835
Buffett classification: The Gruesome
Stock price: 1.56
P/E ratio: 21.28402038664323
Shares outstanding: 31052840
Book value: 15808000
P/B ratio: 3.0644250000000004
Market cap (USD): 48442430.4
Debt to equity: 1.3070597165991902
Current ratio: 0.813615530797034
Quick ratio: 0.813615530797034
Effective tax rate (%): 0
Interest coverage ratio: 2.5528700906344413
COGS to revenue (%): 87.30983302411875
SG&A to revenue (%): 9.554730983302411
Free cash flow (dilution-adjusted): 1372000
Buyback yield (%): 0
Retained earnings: -139560000
Receivables turnover: 2.0378071833648392
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.896513899838892
FCF margin (%): 5.090909090909091
Revenue growth (%): 18.482370526686008
Rule of 40 score: 23.573279617595098